3.22.1 html 147 427 1 false 50 0 false 5 false false R1.htm 000 - Document - Document And Entity Information Sheet http://silopharma.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://silopharma.com/role/ConsolidatedBalanceSheet Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://silopharma.com/role/ConsolidatedBalanceSheet_Parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations Sheet http://silopharma.com/role/ConsolidatedIncomeStatement Consolidated Statements of Operations Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Changes in Stockholders??? Equity Sheet http://silopharma.com/role/ShareholdersEquityType2or3 Consolidated Statements of Changes in Stockholders??? Equity Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows Sheet http://silopharma.com/role/ConsolidatedCashFlow Consolidated Statements of Cash Flows Statements 6 false false R7.htm 006 - Disclosure - Organization and Business Sheet http://silopharma.com/role/OrganizationandBusiness Organization and Business Notes 7 false false R8.htm 007 - Disclosure - Summary of Significant Accounting Policies Sheet http://silopharma.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Fair Value of Financial Instruments and Fair Value Measurements Sheet http://silopharma.com/role/FairValueofFinancialInstrumentsandFairValueMeasurements Fair Value of Financial Instruments and Fair Value Measurements Notes 9 false false R10.htm 009 - Disclosure - Disposal of the Discontinued Operations of the Nfid Business Sheet http://silopharma.com/role/DisposaloftheDiscontinuedOperationsoftheNfidBusiness Disposal of the Discontinued Operations of the Nfid Business Notes 10 false false R11.htm 010 - Disclosure - Notes Receivable Notes http://silopharma.com/role/NotesReceivable Notes Receivable Notes 11 false false R12.htm 011 - Disclosure - Note Payable Sheet http://silopharma.com/role/NotePayable Note Payable Notes 12 false false R13.htm 012 - Disclosure - Stockholders??? Equity Sheet http://silopharma.com/role/StockholdersEquity Stockholders??? Equity Notes 13 false false R14.htm 013 - Disclosure - Income Taxes Sheet http://silopharma.com/role/IncomeTaxes Income Taxes Notes 14 false false R15.htm 014 - Disclosure - Concentrations Sheet http://silopharma.com/role/Concentrations Concentrations Notes 15 false false R16.htm 015 - Disclosure - Commitments and Contingencies Sheet http://silopharma.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 16 false false R17.htm 016 - Disclosure - Subsequent Events Sheet http://silopharma.com/role/SubsequentEvents Subsequent Events Notes 17 false false R18.htm 017 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://silopharma.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://silopharma.com/role/SummaryofSignificantAccountingPolicies 18 false false R19.htm 018 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://silopharma.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://silopharma.com/role/SummaryofSignificantAccountingPolicies 19 false false R20.htm 019 - Disclosure - Fair Value of Financial Instruments and Fair Value Measurements (Tables) Sheet http://silopharma.com/role/FairValueofFinancialInstrumentsandFairValueMeasurementsTables Fair Value of Financial Instruments and Fair Value Measurements (Tables) Tables http://silopharma.com/role/FairValueofFinancialInstrumentsandFairValueMeasurements 20 false false R21.htm 020 - Disclosure - Disposal of the Discontinued Operations of the Nfid Business (Tables) Sheet http://silopharma.com/role/DisposaloftheDiscontinuedOperationsoftheNfidBusinessTables Disposal of the Discontinued Operations of the Nfid Business (Tables) Tables http://silopharma.com/role/DisposaloftheDiscontinuedOperationsoftheNfidBusiness 21 false false R22.htm 021 - Disclosure - Notes Receivable (Tables) Notes http://silopharma.com/role/NotesReceivableTables Notes Receivable (Tables) Tables http://silopharma.com/role/NotesReceivable 22 false false R23.htm 022 - Disclosure - Note Payable (Tables) Sheet http://silopharma.com/role/NotePayableTables Note Payable (Tables) Tables http://silopharma.com/role/NotePayable 23 false false R24.htm 023 - Disclosure - Stockholders??? Equity (Tables) Sheet http://silopharma.com/role/StockholdersEquityTables Stockholders??? Equity (Tables) Tables http://silopharma.com/role/StockholdersEquity 24 false false R25.htm 024 - Disclosure - Income Taxes (Tables) Sheet http://silopharma.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://silopharma.com/role/IncomeTaxes 25 false false R26.htm 025 - Disclosure - Commitments and Contingencies (Tables) Sheet http://silopharma.com/role/CommitmentsandContingenciesTables Commitments and Contingencies (Tables) Tables http://silopharma.com/role/CommitmentsandContingencies 26 false false R27.htm 026 - Disclosure - Organization and Business (Details) Sheet http://silopharma.com/role/OrganizationandBusinessDetails Organization and Business (Details) Details http://silopharma.com/role/OrganizationandBusiness 27 false false R28.htm 027 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://silopharma.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://silopharma.com/role/SummaryofSignificantAccountingPoliciesTables 28 false false R29.htm 028 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of anti-dilutive net loss per share Sheet http://silopharma.com/role/ScheduleofantidilutivenetlosspershareTable Summary of Significant Accounting Policies (Details) - Schedule of anti-dilutive net loss per share Details http://silopharma.com/role/SummaryofSignificantAccountingPoliciesTables 29 false false R30.htm 029 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of basic and diluted net loss per share Sheet http://silopharma.com/role/ScheduleofreconciliationofbasicanddilutednetlosspershareTable Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of basic and diluted net loss per share Details http://silopharma.com/role/SummaryofSignificantAccountingPoliciesTables 30 false false R31.htm 030 - Disclosure - Fair Value of Financial Instruments and Fair Value Measurements (Details) Sheet http://silopharma.com/role/FairValueofFinancialInstrumentsandFairValueMeasurementsDetails Fair Value of Financial Instruments and Fair Value Measurements (Details) Details http://silopharma.com/role/FairValueofFinancialInstrumentsandFairValueMeasurementsTables 31 false false R32.htm 031 - Disclosure - Fair Value of Financial Instruments and Fair Value Measurements (Details) - Schedule of assets and liabilities measured at fair value Sheet http://silopharma.com/role/ScheduleofassetsandliabilitiesmeasuredatfairvalueTable Fair Value of Financial Instruments and Fair Value Measurements (Details) - Schedule of assets and liabilities measured at fair value Details http://silopharma.com/role/FairValueofFinancialInstrumentsandFairValueMeasurementsTables 32 false false R33.htm 032 - Disclosure - Fair Value of Financial Instruments and Fair Value Measurements (Details) - Schedule of activity in the company???s equity investments, at fair value Sheet http://silopharma.com/role/ScheduleofactivityinthecompanysequityinvestmentsatfairvalueTable Fair Value of Financial Instruments and Fair Value Measurements (Details) - Schedule of activity in the company???s equity investments, at fair value Details http://silopharma.com/role/FairValueofFinancialInstrumentsandFairValueMeasurementsTables 33 false false R34.htm 033 - Disclosure - Disposal of the Discontinued Operations of the Nfid Business (Details) Sheet http://silopharma.com/role/DisposaloftheDiscontinuedOperationsoftheNfidBusinessDetails Disposal of the Discontinued Operations of the Nfid Business (Details) Details http://silopharma.com/role/DisposaloftheDiscontinuedOperationsoftheNfidBusinessTables 34 false false R35.htm 034 - Disclosure - Disposal of the Discontinued Operations of the Nfid Business (Details) - Schedule of financial data of the company???s gain from sale of the NFID business Sheet http://silopharma.com/role/ScheduleoffinancialdataofthecompanysgainfromsaleoftheNFIDbusinessTable Disposal of the Discontinued Operations of the Nfid Business (Details) - Schedule of financial data of the company???s gain from sale of the NFID business Details http://silopharma.com/role/DisposaloftheDiscontinuedOperationsoftheNfidBusinessTables 35 false false R36.htm 035 - Disclosure - Disposal of the Discontinued Operations of the Nfid Business (Details) - Schedule of operating result of discontinued operations of the NFID business Sheet http://silopharma.com/role/ScheduleofoperatingresultofdiscontinuedoperationsoftheNFIDbusinessTable Disposal of the Discontinued Operations of the Nfid Business (Details) - Schedule of operating result of discontinued operations of the NFID business Details http://silopharma.com/role/DisposaloftheDiscontinuedOperationsoftheNfidBusinessTables 36 false false R37.htm 036 - Disclosure - Notes Receivable (Details) Notes http://silopharma.com/role/NotesReceivableDetails Notes Receivable (Details) Details http://silopharma.com/role/NotesReceivableTables 37 false false R38.htm 037 - Disclosure - Notes Receivable (Details) - Schedule of notes receivable Notes http://silopharma.com/role/ScheduleofnotesreceivableTable Notes Receivable (Details) - Schedule of notes receivable Details http://silopharma.com/role/NotesReceivableTables 38 false false R39.htm 038 - Disclosure - Note Payable (Details) Sheet http://silopharma.com/role/NotePayableDetails Note Payable (Details) Details http://silopharma.com/role/NotePayableTables 39 false false R40.htm 039 - Disclosure - Note Payable (Details) - Schedule of interest expense Sheet http://silopharma.com/role/ScheduleofinterestexpenseTable Note Payable (Details) - Schedule of interest expense Details http://silopharma.com/role/NotePayableTables 40 false false R41.htm 040 - Disclosure - Stockholders??? Equity (Details) Sheet http://silopharma.com/role/StockholdersEquityDetails Stockholders??? Equity (Details) Details http://silopharma.com/role/StockholdersEquityTables 41 false false R42.htm 041 - Disclosure - Stockholders??? Equity (Details) - Schedule of stock options activities Sheet http://silopharma.com/role/ScheduleofstockoptionsactivitiesTable Stockholders??? Equity (Details) - Schedule of stock options activities Details http://silopharma.com/role/StockholdersEquityTables 42 false false R43.htm 042 - Disclosure - Stockholders??? Equity (Details) - Schedule of warrant activities Sheet http://silopharma.com/role/ScheduleofwarrantactivitiesTable Stockholders??? Equity (Details) - Schedule of warrant activities Details http://silopharma.com/role/StockholdersEquityTables 43 false false R44.htm 043 - Disclosure - Income Taxes (Details) Sheet http://silopharma.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://silopharma.com/role/IncomeTaxesTables 44 false false R45.htm 044 - Disclosure - Income Taxes (Details) - Schedule of effective statutory rate and the provision for income taxes Sheet http://silopharma.com/role/ScheduleofeffectivestatutoryrateandtheprovisionforincometaxesTable Income Taxes (Details) - Schedule of effective statutory rate and the provision for income taxes Details http://silopharma.com/role/IncomeTaxesTables 45 false false R46.htm 045 - Disclosure - Income Taxes (Details) - Schedule of deferred tax asset Sheet http://silopharma.com/role/ScheduleofdeferredtaxassetTable Income Taxes (Details) - Schedule of deferred tax asset Details http://silopharma.com/role/IncomeTaxesTables 46 false false R47.htm 046 - Disclosure - Concentrations (Details) Sheet http://silopharma.com/role/ConcentrationsDetails Concentrations (Details) Details http://silopharma.com/role/Concentrations 47 false false R48.htm 047 - Disclosure - Commitments and Contingencies (Details) Sheet http://silopharma.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://silopharma.com/role/CommitmentsandContingenciesTables 48 false false R49.htm 048 - Disclosure - Commitments and Contingencies (Details) - Schedule of milestone payments Sheet http://silopharma.com/role/ScheduleofmilestonepaymentsTable Commitments and Contingencies (Details) - Schedule of milestone payments Details http://silopharma.com/role/CommitmentsandContingenciesTables 49 false false R50.htm 049 - Disclosure - Commitments and Contingencies (Details) - Schedule of UMB minimum royalty payments Sheet http://silopharma.com/role/ScheduleofUMBminimumroyaltypaymentsTable Commitments and Contingencies (Details) - Schedule of UMB minimum royalty payments Details http://silopharma.com/role/CommitmentsandContingenciesTables 50 false false R51.htm 050 - Disclosure - Commitments and Contingencies (Details) - Schedule of exclusive of value added tax to be amortized Sheet http://silopharma.com/role/ScheduleofexclusiveofvalueaddedtaxtobeamortizedTable Commitments and Contingencies (Details) - Schedule of exclusive of value added tax to be amortized Details http://silopharma.com/role/CommitmentsandContingenciesTables 51 false false R52.htm 051 - Disclosure - Commitments and Contingencies (Details) - Schedule of shall pay UMB Sheet http://silopharma.com/role/ScheduleofshallpayUMBTable Commitments and Contingencies (Details) - Schedule of shall pay UMB Details http://silopharma.com/role/CommitmentsandContingenciesTables 52 false false R53.htm 052 - Disclosure - Subsequent Events (Details) Sheet http://silopharma.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://silopharma.com/role/SubsequentEvents 53 false false All Reports Book All Reports f10k2021_silopharmainc.htm f10k2021ex21-1_silopharma.htm f10k2021ex31-1_silopharma.htm f10k2021ex31-2_silopharma.htm f10k2021ex32-1_silopharma.htm f10k2021ex4-1_silopharma.htm silo-20211231.xsd silo-20211231_cal.xml silo-20211231_def.xml silo-20211231_lab.xml silo-20211231_pre.xml fin_001.jpg http://fasb.org/srt/2021-01-31 http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true